Renaissance Technologies’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-358,200
| Closed | -$75K | – | 4272 |
|
|
2023
Q2 | $75K | Buy |
358,200
+123,200
| +52% | +$21.4K | ﹤0.01% | 3532 |
|
|
2023
Q1 | $38K | Sell |
235,000
-184,600
| -44% | -$82K | ﹤0.01% | 3718 |
|
|
2022
Q4 | $233K | Sell |
419,600
-251,012
| -37% | -$214K | ﹤0.01% | 3351 |
|
|
2022
Q3 | $798K | Sell |
670,612
-90,552
| -12% | -$97.7K | ﹤0.01% | 2634 |
|
|
2022
Q2 | $481K | Sell |
761,164
-196,296
| -21% | -$151K | ﹤0.01% | 3185 |
|
|
2022
Q1 | $1.09M | Buy |
957,460
+591,065
| +161% | +$706K | ﹤0.01% | 2674 |
|
|
2021
Q4 | $824K | Buy |
366,395
+316,995
| +642% | +$796K | ﹤0.01% | 2786 |
|
|
2021
Q3 | $169K | Sell |
49,400
-669,967
| -93% | -$2.07M | ﹤0.01% | 3238 |
|
|
2021
Q2 | $2.15M | Sell |
719,367
-416,700
| -37% | -$1.32M | ﹤0.01% | 2209 |
|
|
2021
Q1 | $3.67M | Sell |
1,136,067
-1,079,907
| -49% | -$3.6M | ﹤0.01% | 1838 |
|
|
2020
Q4 | $4.7M | Buy |
2,215,974
+429,041
| +24% | +$708K | 0.01% | 1632 |
|
|
2020
Q3 | $2.09M | Buy |
1,786,933
+156,295
| +10% | +$161K | ﹤0.01% | 2100 |
|
|
2020
Q2 | $1.48M | Buy |
1,630,638
+245,224
| +18% | +$234K | ﹤0.01% | 2350 |
|
|
2020
Q1 | $1.16M | Buy |
1,385,414
+127,101
| +10% | +$147K | ﹤0.01% | 2352 |
|
|
2019
Q4 | $1.21M | Buy |
1,258,313
+137,373
| +12% | +$151K | ﹤0.01% | 2542 |
|
|
2019
Q3 | $1.16M | Buy |
1,120,940
+118,934
| +12% | +$162K | ﹤0.01% | 2540 |
|
|
2019
Q2 | $1.8M | Buy |
1,002,006
+110,806
| +12% | +$178K | ﹤0.01% | 2382 |
|
|
2019
Q1 | $1.68M | Buy |
891,200
+69,300
| +8% | +$101K | ﹤0.01% | 2409 |
|
|
2018
Q4 | $970K | Buy |
821,900
+85,200
| +12% | +$153K | ﹤0.01% | 2587 |
|
|
2018
Q3 | $2M | Buy |
736,700
+194,000
| +36% | +$401K | ﹤0.01% | 2271 |
|
|
2018
Q2 | $1.04M | Sell |
542,700
-24,800
| -4% | -$50.1K | ﹤0.01% | 2585 |
|
|
2018
Q1 | $1.19M | Sell |
567,500
-150,400
| -21% | -$322K | ﹤0.01% | 2583 |
|
|
2017
Q4 | $1.46M | Sell |
717,900
-892,100
| -55% | -$1.85M | ﹤0.01% | 2504 |
|
|
2017
Q3 | $2.14M | Buy |
1,610,000
+440,127
| +38% | +$547K | ﹤0.01% | 2268 |
|
|
2017
Q2 | $1.84M | Sell |
1,169,873
-269,368
| -19% | -$520K | ﹤0.01% | 2302 |
|
|
2017
Q1 | $4.65M | Sell |
1,439,241
-260,759
| -15% | -$642K | 0.01% | 1720 |
|
|
2016
Q4 | $2.29M | Sell |
1,700,000
-160,900
| -9% | -$210K | ﹤0.01% | 2152 |
|
|
2016
Q3 | $2.9M | Buy |
1,860,900
+1,111,200
| +148% | +$1.71M | 0.01% | 1969 |
|
|
2016
Q2 | $997K | Buy |
749,700
+737,400
| +5,995% | +$3.45M | ﹤0.01% | 2538 |
|
|
2016
Q1 | $65K | Sell |
12,300
-145,800
| -92% | -$892K | ﹤0.01% | 3256 |
|
|
2015
Q4 | $1.24M | Sell |
158,100
-719,400
| -82% | -$6.19M | ﹤0.01% | 2363 |
|
|
2015
Q3 | $7.42M | Sell |
877,500
-320,850
| -27% | -$2.96M | 0.02% | 1117 |
|
|
2015
Q2 | $13.1M | Buy |
1,198,350
+530,350
| +79% | +$6.81M | 0.03% | 770 |
|
|
2015
Q1 | $9.34M | Buy |
668,000
+466,400
| +231% | +$7.13M | 0.02% | 972 |
|
|
2014
Q4 | $3.4M | Buy |
201,600
+158,800
| +371% | +$2.31M | 0.01% | 1499 |
|
|
2014
Q3 | $574K | Sell |
42,800
-155,800
| -78% | -$1.86M | ﹤0.01% | 2263 |
|
|
2014
Q2 | $2.53M | Sell |
198,600
-299,940
| -60% | -$3.12M | 0.01% | 1604 |
|
|
2014
Q1 | $5.93M | Sell |
498,540
-265,060
| -35% | -$3.56M | 0.01% | 1162 |
|
|
2013
Q4 | $10.5M | Buy |
763,600
+556,000
| +268% | +$7.85M | 0.03% | 783 |
|
|
2013
Q3 | $3.62M | Sell |
207,600
-49,100
| -19% | -$940K | 0.01% | 1340 |
|
|
2013
Q2 | $4.16M | Buy |
+256,700
| New | +$7.94M | 0.01% | 1188 |
|
Other funds holding INFI
Renaissance Technologies's INFI Position: Q3 2023 in Review
Renaissance Technologies sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 358,200 shares — an estimated $75K sold.
Renaissance Technologies first reported a position in INFI in Q2 2013 and held it in 41 quarters. The position peaked at $13.1M in Q2 2015. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.
- Renaissance Technologies reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- Renaissance Technologies sold 358,200 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $75K.
- Renaissance Technologies first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 41 quarters.
- Renaissance Technologies's Infinity Pharmaceuticals, Inc. position peaked at $13.1M in Q2 2015.
- 3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.